241
Participants
Start Date
February 20, 2018
Primary Completion Date
January 7, 2019
Study Completion Date
January 7, 2019
Insulin glargine/Lixisenatide
Insulin glargine (100 units per milliliter \[U/mL\]) and lixisenatide (33 micrograms per milliliter \[mcg/mL\]) self administered by a subcutaneous injection using a prefilled pen. Dose was individually titrated to achieve target fasting self-monitoring of plasma glucose (SMPG) of 80 to 100 milligrams per deciliter (mg/dL) (4.4 to 5.6 millimoles per liter \[mmol/L\]) while avoiding hypoglycemia.
Insulin glargine (HOE901)
Insulin glargine 100 U/mL self-administered by a subcutaneous injection using a prefilled pen. Dose was individually titrated to achieve target fasting SMPG of 80 to 100 mg/dL (4.4 to 5.6 mmol/L) while avoiding hypoglycemia.
Background therapy
Oral Anti diabetics Drugs (OADs) administered orally according to the locally approved label.
Investigational Site Number 8400003, The Bronx
Investigational Site Number 8400062, Philadelphia
Investigational Site Number 8400044, Manassas
Investigational Site Number 8400061, Rockville
Investigational Site Number 8400065, Baltimore
Investigational Site Number 8400033, Richmond
Investigational Site Number 8400068, Norfolk
Investigational Site Number 8400043, Columbia
Investigational Site Number 8400025, Atlanta
Investigational Site Number 8400051, Atlanta
Investigational Site Number 8400093, Atlanta
Investigational Site Number 8400075, Jacksonville
Investigational Site Number 8400041, Gainesville
Investigational Site Number 8400016, Miami Lakes
Investigational Site Number 8400036, Miami
Investigational Site Number 8400017, Miami
Investigational Site Number 8400094, Tampa
Investigational Site Number 8400035, St. Petersburg
Investigational Site Number 8400028, Port Charlotte
Investigational Site Number 8400014, Ocoee
Investigational Site Number 8400072, Montgomery
Investigational Site Number 8400079, Chelsea
Investigational Site Number 8400001, Flint
Investigational Site Number 8400031, Des Plaines
Investigational Site Number 8400057, Gurnee
Investigational Site Number 8400064, Evanston
Investigational Site Number 8400038, Chicago
Investigational Site Number 8400088, Chicago
Investigational Site Number 8400030, Gretna
Investigational Site Number 8400009, New Orleans
Investigational Site Number 8400077, Little Rock
Investigational Site Number 8400095, Little Rock
Investigational Site Number 8400013, Little Rock
Investigational Site Number 8400021, Dallas
Investigational Site Number 8400096, Lufkin
Investigational Site Number 8400040, Fort Worth
Investigational Site Number 8400045, Houston
Investigational Site Number 8400002, Humble
Investigational Site Number 8400008, Splendora
Investigational Site Number 8400055, Spring
Investigational Site Number 8400070, Sugar Land
Investigational Site Number 8400085, Sugar Land
Investigational Site Number 8400059, Webster
Investigational Site Number 8400039, Kerrville
Investigational Site Number 8400027, San Antonio
Investigational Site Number 8400083, San Antonio
Investigational Site Number 8400054, Englewood
Investigational Site Number 8400090, Las Vegas
Investigational Site Number 8400082, Las Vegas
Investigational Site Number 8400015, Los Angeles
Investigational Site Number 8400011, Los Angeles
Investigational Site Number 8400301, Los Angeles
Investigational Site Number 8400302, Los Angeles
Investigational Site Number 8400303, Los Angeles
Investigational Site Number 8400304, Los Angeles
Investigational Site Number 8400092, Huntington Park
Investigational Site Number 8400049, Cerritos
Investigational Site Number 8400024, Van Nuys
Investigational Site Number 8400060, Burbank
Investigational Site Number 8400042, Rancho Cucamonga
Investigational Site Number 8400084, Pomona
Investigational Site Number 8400081, Pomona
Investigational Site Number 8400078, Chula Vista
Investigational Site Number 8400047, Escondido
Investigational Site Number 8400091, San Diego
Investigational Site Number 8400037, Temecula
Investigational Site Number 8400074, Santa Ana
Investigational Site Number 8400066, Fountain Valley
Investigational Site Number 8400052, Anaheim
Investigational Site Number 8400069, Anaheim
Investigational Site Number 8400053, Orange
Investigational Site Number 8400007, Ventura
Investigational Site Number 8400063, San Carlos
Investigational Site Number 8400087, Vallejo
Investigational Site Number 8400048, Oakland
Investigational Site Number 8400050, Greenbrae
Investigational Site Number 8400006, Los Gatos
Investigational Site Number 8400086, San Jose
Investigational Site Number 8400029, Richland
Investigational Site Number 8400076, Anaheim
Investigational Site Number 8400023, Hamden
Investigational Site Number 8400097, St. Petersburg
Investigational Site Number 8400005, Savannah
Investigational Site Number 8400012, Flint
Investigational Site Number 8400018, Linden
Lead Sponsor
Sanofi
INDUSTRY